$43.730
-0.455 (-1.04%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SUPN por análisis de gráficos similares
Alphio's SUPN stock price prediction model matches the current Supernus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $41.19 (-5.80%). The 1-week path is $43.97 (+0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Supernus Pharmaceuticals Inc?
Supernus Pharmaceuticals Inc is currently a hold. The stock is priced at $43.73, significantly below the analyst price target of $67, indicating potential upside. However, the RSI is at a low 22.035, suggesting the stock is oversold, which could lead to a rebound. The recent merger with Indivior could provide long-term benefits, but the company reported a net loss of over $58 million in Q2, which raises concerns about profitability. Additionally, insider selling has surged by 2510.70%, indicating potential lack of confidence from insiders, which is a risk to consider.
SUPN cerró en $43.73 el Friday, tras bajar -1.04%
Supernus Pharmaceuticals Inc (SUPN) last closed at $43.73, losing -1.04%. These facts feed the 1-day and 1-week SUPN price prediction above.
Consenso de analistas
Supernus Pharmaceuticals Inc (SUPN): 6 comprar, 2 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Supernus Pharmaceuticals Inc (SUPN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SUPN, ordenadas por similitud.
Análisis de estacionalidad de SUPN
Historically the probability of a positive August return for SUPN is 66.67%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SUPN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $27.38 | $29.28 | $33.82 | -33.05% |
| Sep 2026 | $25.93 | $29.28 | $30.36 | -33.05% |
| Oct 2026 | $32.04 | $39.52 | $40.25 | -9.63% |
| Nov 2026 | $29.48 | $29.51 | $33.72 | -32.51% |
| Dec 2026 | $22.31 | $29.28 | $33.77 | -33.05% |
En 2026, se proyecta que Supernus Pharmaceuticals Inc (SUPN) oscile entre $22.31 y $40.25.
Previsión mensual de Supernus Pharmaceuticals Inc para 2026
En Aug de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.28, con un mínimo de $27.38 y un máximo de $33.82.
En Sep de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.28, con un mínimo de $25.93 y un máximo de $30.36.
En Oct de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $39.52, con un mínimo de $32.04 y un máximo de $40.25.
En Nov de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.51, con un mínimo de $29.48 y un máximo de $33.72.
En Dec de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.28, con un mínimo de $22.31 y un máximo de $33.77.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.